Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Comment by MrMonkon Mar 25, 2013 8:10pm
206 Views
Post# 21166018

RE: RE: RE: RE: Ouch...

RE: RE: RE: RE: Ouch...

Very well put Sallgewd.  NOTHING has changed fundamentally.  People sell for their reasons, not ours.  Someone clearly needed some cash today and volatile swings will happen with thinly traded stocks like NOX. Don't mean to be insensitive, however if you can't stomach the swings, sell your shares and sleep tight.

MDA is handling the next 43-101.  They are re-assessing the previous 43-101 done by SGS and I believe we'll see an additional 200,000 or 300,000 oz BEFORE we even factor in Phase 2 drilling.  Lots of gold in dem hils.

Would have been nice to pick it up at 0.19 instead of 0.30 or 0.40 for anyone who's fully invested and can't average down.  Oh well, timing the bottoms is fruitless.  If you feel, like I do, that this will be a $1.50 - $2.00 stock over time, you'll still have done well buying at 0.30 or 0.40.

 

- MM

<< Previous
Bullboard Posts
Next >>